Erica Abney, PA
Surgical · Tuscaloosa, ALNPI 1003236019
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Intrinsic Therapeutics accounts for 65.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $4,554 and has fallen 99.7% since, to $16 in 2025. Among surgical clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $110.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intrinsic Therapeutics$5K
- Boston Scientific$762
- Spineology Inc.$609
- Medical Device Business Services, Inc.$371
- Radius Health, Inc.$162
- Centinel Spine, LLC$145
- plus $572 from 16 others
What the payments were for
- Consulting fees$4,50059%
- Speaking & faculty fees$5007%
- Food & beverage$2,34731%
- Education$2744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intrinsic Therapeutics | 14 | $5,000 |
| Boston Scientific | 14 | $762 |
| Spineology Inc. | 3 | $609 |
| Medical Device Business Services, Inc. | 3 | $371 |
| Radius Health, Inc. | 9 | $162 |
| Centinel Spine, LLC | 1 | $145 |
| Johnson & Johnson(2 entities) | 2 | $129 |
| Amgen | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| AstraZeneca | 3 | $43 |
| Globus Medical | 1 | $41 |
| Nevro Corp. | 2 | $32 |
| Spine Wave, Inc. | 1 | $31 |
| AbbVie | 2 | $29 |
| Alvogen Inc | 1 | $29 |
| Boehringer Ingelheim | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $21 |
| Medtronic | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $17 |
| Vericel Corporation | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,622 in reported general payments places this provider in the 95th percentile of 162 surgical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 64 | $642 |
| Methocarbamol | 42 | $333 |
| Celecoxib | 15 | $305 |
| Methylprednisolone | 25 | $183 |
| Cyclobenzaprine Hcl | 22 | $75 |
| Meloxicam | 16 | $24 |
Paid to pharmacies, not to this prescriber.
Other surgical in Tuscaloosa
- Michael CilimbergTuscaloosa$10K
- Heather ForsonBirmingham$8K
- Kelli HeerDothan$8K
- Suzanne Powe VickersBirmingham$8K
- Jennifer RawlingsVestavia$7K
- Chelsi DavisJasper$7K
- Samuel MurphreeBirmingham$6K
- Michael JordanHuntsville$5K
- Edith AgeeMontgomery$5K
- Elizabeth BrigliaHuntsville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.